Chemoinformaics analysis of P-MENTHA-3-EN-8-OL
| Molecular Weight | 168.28 | nRot | 2 |
| Heavy Atom Molecular Weight | 148.12 | nRig | 6 |
| Exact Molecular Weight | 168.151 | nRing | 1 |
| Solubility: LogS | -2.872 | nHRing | 0 |
| Solubility: LogP | 3.219 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 32.5079 |
| nHD | 1 | BPOL | 20.0641 |
| QED | 0.629 |
| Synth | 3.58 |
| Natural Product Likeliness | 1.411 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.265 |
| MDCK | 0.0000184 |
| BBB | 0.968 |
| PPB | 0.906634 |
| VDSS | 2.356 |
| FU | 0.115074 |
| CYP1A2-inh | 0.538 |
| CYP1A2-sub | 0.476 |
| CYP2c19-inh | 0.154 |
| CYP2c19-sub | 0.745 |
| CYP2c9-inh | 0.068 |
| CYP2c9-sub | 0.441 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.54 |
| CYP3a4-inh | 0.025 |
| CYP3a4-sub | 0.226 |
| CL | 9.684 |
| T12 | 0.378 |
| hERG | 0.004 |
| Ames | 0.007 |
| ROA | 0.031 |
| SkinSen | 0.13 |
| Carcinogencity | 0.76 |
| EI | 0.908 |
| Respiratory | 0.867 |
| NR-Aromatase | 0.017 |
| Antiviral | No |
| Prediction | 0.817391 |